Jorgensen Sarah C J, Yeung Samantha L, Zurayk Mira, Terry Jill, Dunn Maureen, Nieberg Paul, Pallares Jean, Wong-Beringer Annie
Department of Pharmacy, Huntington Hospital, Pasadena, California.
University of Southern California, School of Pharmacy, Los Angeles, California.
Open Forum Infect Dis. 2018 May 2;5(6):ofy101. doi: 10.1093/ofid/ofy101. eCollection 2018 Jun.
The complex and fast-paced emergency department (ED) practice setting presents unique challenges that demand a tailored approach to antimicrobial stewardship. In this article, we describe the strategies applied by 1 institution's antimicrobial stewardship program (ASP) that were successful in improving prescribing practices and outcomes for urinary tract infection (UTI) in the ED.
Core strategies included pre-implementation research characterizing the patient population, antimicrobial resistance patterns, prescribing behavior, and morbidity related to infection; collaboration across multiple disciplines; development and implementation of a UTI treatment algorithm; education to increase awareness of the algorithm and the background and rationale supporting it; audit and feedback; and early evaluation of post-implementation outcomes.
We observed a rapid change in prescribing post-implementation with increased empiric nitrofurantoin use and reduced cephalosporin use ( < .05). Our elevation of nitrofurantoin to firstline status was supported by our post-implementation analysis showing that its use was independently associated with reduced 30-day return visits (adjusted odds ratio, 0.547; 95% confidence interval, 0.312-0.960). Furthermore, despite a shift to a higher risk population and a corresponding decrease in antimicrobial susceptibility rates post-implementation, the preferential use of nitrofurantoin did not result in higher bug-drug mismatches while 30-day return visits to the ED remained stable.
We demonstrate that an outcomes-based ASP can impart meaningful change to knowledge and attitudes affecting prescribing practices in the ED. The success of our program may be used by other institutions as support for ASP expansion to the ED.
急诊科复杂且节奏快的诊疗环境带来了独特的挑战,需要采用量身定制的抗菌药物管理方法。在本文中,我们描述了一家机构的抗菌药物管理项目(ASP)所应用的策略,这些策略成功改善了急诊科尿路感染(UTI)的处方开具实践及治疗结果。
核心策略包括实施前研究,以明确患者群体特征、抗菌药物耐药模式、处方行为以及与感染相关的发病率;多学科协作;制定并实施UTI治疗算法;开展教育以提高对该算法及其支持背景和原理的认识;进行审核与反馈;以及对实施后的结果进行早期评估。
我们观察到实施后处方开具迅速发生变化,呋喃妥因的经验性使用增加,头孢菌素的使用减少(<0.05)。实施后的分析表明,呋喃妥因使用与30天复诊率降低独立相关(调整后的优势比为0.547;95%置信区间为0.312 - 0.960),这支持了我们将呋喃妥因提升至一线地位的做法。此外,尽管实施后转向了更高风险的人群且抗菌药物敏感性率相应下降,但优先使用呋喃妥因并未导致更高的细菌与药物不匹配情况,同时急诊科的30天复诊率保持稳定。
我们证明了基于结果的ASP可以对影响急诊科处方开具实践的知识和态度产生有意义的改变。我们项目的成功经验可供其他机构用于支持将ASP扩展至急诊科。